Efficacy and safety of different doses and durations of intravenous immunoglobulin treatment for immune thrombocytopenic purpura

被引：0
|
作者：
Lavon, O. [1 ,2 ]
Noy, R. [1 ]
机构：
[1] Technion, Rappaport Fac Med, Haifa, Israel
[2] Carmel Hosp, Clin Pharmacol & Toxicol, Haifa, Israel
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2019年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
EACPT-1058
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of a new intravenous immunoglobulin product in patients with chronic immune thrombocytopenic purpura
    Robak, Tadeusz
    Salama, Abdulgabar
    Kovaleva, Lidia
    Vyhovska, Yaroslava I.
    Davies, Simon
    Mazzucconi, Maria G.
    Zenker, Othmar
    BLOOD, 2007, 110 (11) : 393A - 394A
  • [2] Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpura
    Apte, Shashikant
    Navarro-Puerto, Jordi
    Damodar, Sharat
    Ramanan, Vijay
    John, Joseph
    Kato, Giraldo
    Ross, Cecil
    Shah, Chirag
    Torres, Marcela
    Fu, Chieh-Lin 'Kathy'
    Rucker, Karen
    Pinciaro, Paul
    Barrera, Gladis
    Esperanca Aragones, Maria
    Ayguasanosa, Jaume
    IMMUNOTHERAPY, 2019, 11 (02) : 81 - 89
  • [3] IMMUNE THROMBOCYTOPENIC PURPURA AND INTRAVENOUS IMMUNOGLOBULIN
    IMBACH, P
    CANCER, 1991, 68 (06) : 1422 - 1425
  • [4] The treatment of idiopathic thrombocytopenic purpura in adults: The efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia
    Pugina, SA
    Evdokimova, NM
    Rastorguev, GG
    Samoilova, OS
    Sorokina, IV
    Sidnev, GV
    Vasilyev, DM
    Anastasiev, VV
    Milovidova, OV
    Molodovskaya, EV
    Borovkov, NN
    TERAPEVTICHESKII ARKHIV, 1999, 71 (08) : 50 - 54
  • [5] Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura
    Aledort, L. M.
    Salama, A.
    Kovaleva, L.
    Robak, T.
    Newland, A. C.
    Nugent, D. J.
    Brenner, B.
    Zenker, O.
    HEMATOLOGY, 2007, 12 (04) : 289 - 295
  • [6] INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION IN THE TREATMENT OF SEVERE CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA
    CARROLL, RR
    NOYES, WD
    ROSSE, WF
    KITCHENS, CS
    AMERICAN JOURNAL OF MEDICINE, 1984, 76 (3A): : 181 - 186
  • [7] Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura
    Jin, F
    Balthasar, JP
    HUMAN IMMUNOLOGY, 2005, 66 (04) : 403 - 410
  • [8] Treatment of immune thrombocytopenic purpura in pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G.
    Buteler, C
    Colombo, H
    Gabosi, G
    Manfredi, MJ
    Montero, S
    Pasquali, MA
    Rougier, C
    Sisti, AM
    MEDICINA-BUENOS AIRES, 2001, 61 (05) : 522 - 528
  • [9] Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin:: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies
    Wolf, HH
    Davies, SV
    Borte, M
    Caulier, MT
    Williams, PE
    Bernuth, HV
    Egner, W
    Sklenar, I
    Adams, C
    Späth, P
    Morell, A
    Andresen, I
    VOX SANGUINIS, 2003, 84 (01) : 45 - 53
  • [10] Therapy of patients with chronic immune thrombocytopenic purpura (ITP): Efficacy, tolerability, and safety of a new nanoflltered intravenous immunoglobulin
    Wolf, HH
    Davies, S
    Smith, G
    Sklenar, I
    Adams, C
    Andresen, I
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 389 - 395
12345